April 30, 2015
Increase in dividend to EUR 0.75 per share Large majority for resolution approving work of Management Board and Supervisory Board Gerresheimer takes leave of...
More April 30, 2015
Duesseldorf, April 30, 2015 – At its meeting following today’s Annual General Meeting, the Supervisory Board of Gerresheimer AG elected Dr. Axel Herberg (57) as...
More April 14, 2015
Revenues up 1.4% to EUR 301.8m (organic growth -2.4%) Adjusted EBITDA growth of 7.2% to EUR 51.0m (Q1 2014: EUR 47.6m) Net income climbs 22.8% to EUR 12.7m...
More February 11, 2015
Revenues up 1.9% (3.7% organically) to EUR 1,290.0m Adjusted EBITDA totals EUR 258.5m at constant exchange rates Earnings per share up 6.6% to EUR 2.11 ...
More October 22, 2014
Düsseldorf/Dongguan City (People’s Republic of China), October 22, 2014 – Gerresheimer AG, an internationally leading partner to the pharma and healthcare...
More October 08, 2014
Gerresheimer sees good growth opportunities in long-term megatrends of pharma and healthcare Growing importance of drug delivery and dosage devices in Western...
More October 08, 2014
Revenues up 2.2% to EUR 323.9m (+3.2% at constant exchange rates) Adjusted EBITDA with slight improvement on prior-year quarter at EUR 62.1m Net income...
More July 10, 2014
Revenues up 2.6% to EUR 335.4m (6.0% at constant exchange rates) Adjusted EBITDA rises 9.1% to EUR 65.1m (14.1% at constant exchange rates) Net income grows...
More April 30, 2014
Dividend raised to EUR 0.70 per share Management Board and Supervisory Board given formal approval by large majority Dr. Axel Herberg new member of the...
More March 10, 2014
Düsseldorf/Peachtree City (Georgia/USA), March 10, 2014 – Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry, is...
More 